You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 29 No. 2, August 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

An Anatomy of Schizophrenia?

Janice R. Stevens, MD

Arch Gen Psychiatry. 1973;29(2):177-189.


Abstract

The particular value of dopamine blocking agents in the treatment of Schizophrenia, the nearly unique distribution of dopamine axons to neostriatum and limbic striatum, and the special anatomic relationship of striatum to limbic structures are considered in relation to clinical, electroencephalographic, and experimental data which suggest that preemption of consciousness by characteristic fear, sense of unreality, or heightened or distorted sexual and sensory perception in schizophrenic patients is closely linked to the physiology of the limbic system and its striatal "filter."

Anatomic and physiologic studies indicate that limbic striatum consisting of nucleus accumbens, olfactory tubercle, and nucleus of stria terminalis resembles caudate putamen not only in ultrastructure and histochemistry, but also as a recipient of efferents from limbic cortex, amygdala, and hippocampus in a pattern that remarkably parallels the projections of neocortex on neostriatum, the inputs and outputs providing the major difference.



Author Affiliations

Boston

From the Department of Psychiatry, Massachusetts General Hospital and the Erich Lindemann Mental Health Center, Boston. Dr. Stevens was Visiting Associate Professor of Psychiatry, Harvard Medical School (1971 to 1973) and is now with the Department of Neurology, University of Oregon School of Medicine, Portland.


Footnotes

Accepted for publication April 13, 1973.

Presented in part at the annual meeting of the American Academy of Neurology, Boston, April 24, 1973.

Reprint requests to Department of Neurology, University of Oregon School of Medicine, Portland, OR 97201 (Dr. Stevens).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Preliminary Attempt to Personalize Risperidone Dosing Using Drug-Drug Interactions and Genetics: Part II
de Leon et al.
Psychosomatics 2008;49:347-361.
FULL TEXT  

A Preliminary Attempt to Personalize Risperidone Dosing Using Drug-Drug Interactions and Genetics: Part I
de Leon et al.
Psychosomatics 2008;49:258-270.
ABSTRACT | FULL TEXT  

Acknowledgments of Anatomical Advances
HEIMER
Am. J. Psychiatry 2004;161:768-768.
FULL TEXT  

The Extended Amygdala and the Dopamine System: Another Piece of the Dopamine Puzzle
Fudge and Emiliano
J. Neuropsychiatry Clin. Neurosi. 2003;15:306-316.
ABSTRACT | FULL TEXT  

Ionotropic Glutamate Receptors and Expression of N-Methyl-D-Aspartate Receptor Subunits in Subregions of Human Hippocampus: Effects of Schizophrenia
Gao et al.
Am. J. Psychiatry 2000;157:1141-1149.
ABSTRACT | FULL TEXT  

The neuropathology of schizophrenia: A critical review of the data and their interpretation
Harrison
Brain 1999;122:593-624.
ABSTRACT | FULL TEXT  

Considering the Role of the Amygdala in Psychotic Illness: A Clinicopathological Correlation
Fudge et al.
J. Neuropsychiatry Clin. Neurosi. 1998;10:383-394.
ABSTRACT | FULL TEXT  

Effects of Acute and Repeated Administration of Amisulpride, a Dopamine D2/D3 Receptor Antagonist, on the Electrical Activity of Midbrain Dopaminergic Neurons
Di Giovanni et al.
J. Pharmacol. Exp. Ther. 1998;287:51-57.
ABSTRACT | FULL TEXT  

Delusional Misidentification in Association With Parkinsonism
Roane et al.
J. Neuropsychiatry Clin. Neurosi. 1998;10:194-198.
ABSTRACT | FULL TEXT  

Brain Anatomic Magnetic Resonance Imaging in Childhood-Onset Schizophrenia
Frazier et al.
Arch Gen Psychiatry 1996;53:617-624.
ABSTRACT  

Glutamate Receptor Dysfunction and Schizophrenia
Olney and Farber
Arch Gen Psychiatry 1995;52:998-1007.
ABSTRACT  

Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging
Andreasen et al.
Science 1994;266:294-298.
ABSTRACT  

Schizophrenia
Carpenter and Buchanan
NEJM 1994;330:681-690.
FULL TEXT  

Assessing the Validity of an Animal Model of Deficient Sensorimotor Gating in Schizophrenic Patients
Swerdlow et al.
Arch Gen Psychiatry 1994;51:139-154.
ABSTRACT  

Limbic System Abnormalities Identified in Schizophrenia Using Positron Emission Tomography With Fluorodeoxyglucose and Neocortical Alterations With Deficit Syndrome
Tamminga et al.
Arch Gen Psychiatry 1992;49:522-530.
ABSTRACT  

Abnormal Reinnervation as a Basis for Schizophrenia: A Hypothesis
Stevens
Arch Gen Psychiatry 1992;49:238-243.
ABSTRACT  

Limbic Structures and Lateral Ventricle in Schizophrenia: A Quantitative Postmortem Study
Heckers et al.
Arch Gen Psychiatry 1990;47:1016-1022.
ABSTRACT  

Developmental Abnormalities of the Corpus Callosum in Schizophrenia
Swayze et al.
Arch Neurol 1990;47:805-808.
ABSTRACT  

Sensorimotor Gating and Schizophrenia: Human and Animal Model Studies
Braff and Geyer
Arch Gen Psychiatry 1990;47:181-188.
ABSTRACT  

Hippocampal Pathologic Findings in Schizophrenia: A Morphometric Study
Jeste and Lohr
Arch Gen Psychiatry 1989;46:1019-1024.
ABSTRACT  

Quantitative Cytoarchitectural Studies of the Cerebral Cortex of Schizophrenics
Benes et al.
Arch Gen Psychiatry 1986;43:31-35.
ABSTRACT  

Basal Ganglia and Limbic System Pathology in Schizophrenia: A Morphometric Study of Brain Volume and Shrinkage
Bogerts et al.
Arch Gen Psychiatry 1985;42:784-791.
ABSTRACT  

Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients
Pickar et al.
Science 1984;225:954-957.
ABSTRACT  

The Effects of Ceruletide in Schizophrenia
Hommer et al.
Arch Gen Psychiatry 1984;41:617-619.
ABSTRACT  

Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons
White and Wang
Science 1983;221:1054-1057.
ABSTRACT  

Haloperidol-induced plasticity of axon terminals in rat substantia nigra
Benes et al.
Science 1983;221:969-971.
ABSTRACT  

Altered P300 Topography in Schizophrenia
Morstyn et al.
Arch Gen Psychiatry 1983;40:729-734.
ABSTRACT  

Neuropathology of Schizophrenia
Stevens
Arch Gen Psychiatry 1982;39:1131-1139.
ABSTRACT  

CSF Levels of {gamma}-Aminobutyric Acid in Schizophrenia: Low Values in Recently Ill Patients
van Kammen et al.
Arch Gen Psychiatry 1982;39:91-97.
ABSTRACT  

Organic Brain Syndromes
McEVOY
ANN INTERN MED 1981;95:212-220.
ABSTRACT  

Lesions of the Nucleus Ansae Peduncularis in Neuropsychiatric Disease
Averback
Arch Neurol 1981;38:230-235.
ABSTRACT  

Telemetered EEG-EOG During Psychotic Behaviors of Schizophrenia
Stevens et al.
Arch Gen Psychiatry 1979;36:251-262.
ABSTRACT  

Electroencephalographic Similarities Between Chronic Alcoholics and Chronic, Nonparanoid Schizophrenics
Coger et al.
Arch Gen Psychiatry 1979;36:91-94.
ABSTRACT  

Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release
Raymond et al.
Science 1978;200:1173-1175.
ABSTRACT  

Increased Norepinephrine Levels and Decreased Dopamine-{beta}-Hydroxylase Activity in Primary Autism
Lake et al.
Arch Gen Psychiatry 1977;34:553-556.
ABSTRACT  

Reduced Growth Hormone Responses to Amphetamine in "Endogenous" Depressive Patients: Studies in Normal, "Reactive" and "Endogenous" Depressive, Schizophrenic, and Chronic Alcoholic Subjects
Langer et al.
Arch Gen Psychiatry 1976;33:1471-1475.
ABSTRACT  

The Effect of Neuroleptics on Serum Prolactin in Schizophrenic Patients
Meltzer and Fang
Arch Gen Psychiatry 1976;33:279-286.
ABSTRACT  

Dopamine-Sensitive Adenylyl Cyclase in Human Caudate Nucleus: A Study in Control Subjects and Schizophrenic Patients
Carenzi et al.
Arch Gen Psychiatry 1975;32:1056-1059.
ABSTRACT  

Dopamine receptors in the brain
Iversen
Science 1975;188:1084-1089.
 

Adenosine 3',5'-Monophosphate Content in Rat Caudate Nucleus: Demonstration of Dopaminergic and Adrenergic and Receptors
Forn et al.
Science 1974;186:1118-1120.
ABSTRACT  

Biogenic Amines in Autistic and Atypical Children: Cerebrospinal Fluid Measures of Homovanillic Acid and 5-Hydroxyindoleacetic Acid
Cohen et al.
Arch Gen Psychiatry 1974;31:845-853.
ABSTRACT  

Serum Prolactin Levels in Unmedicated Schizophrenic Patients
Meltzer et al.
Arch Gen Psychiatry 1974;31:564-569.
ABSTRACT  

Central Dopamine Turnover in Schizophrenic Syndromes
Bowers
Arch Gen Psychiatry 1974;31:50-54.
ABSTRACT  

Eye-Tracking Patterns in Schizophrenia
Stevens et al.
Science 1974;184:1201-1204.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.